Vascular endothelial growth factor antagonist modulates leukocyte trafficking and protects mouse livers against ischemia/reperfusion injury

American Journal of Pathology

Volumn 168, Issue 2, 2006, Pages 695-705

  Tsuchihashi, Sei Ichiro ^a   Ke, Bibo ^a   Kaldas, Fady ^a   Flynn, Evelyn ^b   Busuttil, Ronald W ^a   Briscoe, David M ^b   Kupiec Weglinski, Jerzy W ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HEME OXYGENASE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTRALIZING ANTIBODY; PROTEIN BCL 2; PROTEIN BCL XL; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INFILTRATION; CELL TRANSPORT; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME BLOOD LEVEL; GENE EXPRESSION; HISTOLOGY; HYPOXIA; INFLAMMATION; LEUKOCYTE; LIVER CELL; LIVER CELL DAMAGE; LIVER ISCHEMIA; LIVER PROTECTION; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NICK END LABELING; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPERFUSION INJURY; T LYMPHOCYTE;

EID: 33244479196     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.050759     Document Type: Article

References (41)

1. Farmer DG, Amersi F, Busuttil RW, Kupiec-Weglinski JW: Current concepts in ischemia and reperfusion injury in the liver. Transplant Rev 2000, 14:106-126
2. Fondevila C, Busuttil RW, Kupiec-Weglinski JW: Hepatic ischemia/reperfusion injury: a fresh look. Exp Mol Pathol 2003, 74:86-93
3. Teoh NC, Farrell GC: Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol 2003, 18:891-902
4. Reinders ME, Sho M, Izawa A, Wang P, Mukhopadhyay D, Koss KE, Geehan CS, Luster AD, Sayegh MH, Briscoe DM: Proinflammalory functions of vascular endothelial growth factor in alloimmunity. J Clin Invest 2003, 112:1655-1665
5. Levy AP, Levy NS, Wegner S, Goldberg MA: Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 1995, 270:13333-13340
6. Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992, 359:843-845
7. Shweiki D, Neeman M, Itin A, Keshet E: Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc Natl Acad Sci USA 1995, 92:768-772
8. Plate KH, Breier G, Weich HA, Risau W: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992, 359:845-848
9. Ke B, Shen XD, Gao F, Tsuchihashi S, Farmer D, Briscoe DM, Busuttil RW, Kupiec-Weglinski JW: The CD154-CD40 T cell costimulation pathway in liver ischemia and reperfusion inflammatory responses. Transplantation 2005, 79:1110-1115
10. Boros P, Tarcsafalvi A, Wang L, Megyesi J, Liu J, Miller CM: Intrahepatic expression and release of vascular endothelial growth factor following orthotopic liver transplantation in the rat. Transplantation 2001, 72:805-811
11. Tsurui Y, Sho M, Kuzumoto Y, Hamada K, Akashi S, Kashizuka H, Ikeda N, Nomi T, Mizuno T, Kanehiro H, Nakajima Y: Dual role of vascular endothelial growth factor in hepatic ischemia-reperfusion injury. Transplantation 2005, 79:1110-1115
12. Abraham D, Taghavi S, Riml P, Paulus P, Hofmann C, Baumann C, Kocher A, Klepetko W, Aharinejad S: VEGF-A and -C but not -B mediate increased vascular permeability in preserved lung grafts. Transplantation 2002, 73:1703-1706
13. Mukhopadhyay D, Knebelmann B, Cohen HT, Ananth S, Sukhatme VP: The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity. Mol Cell Biol 1997, 17:5629-5639
14. Mukhopadhyay D, Tsiokas L, Zhou XM, Foster D, Brugge JS, Sukhatme VP: Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 1995, 375:577-581
15. Pal S, Claffey K, Dvorak HF, Mukhopadhyay D: The von Hippel-Lindau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways. J Biol Chem 1997, 272:27509-27512
16. Zarember KA, Malech HL: HIF-1alpha: a master regulator of innate host defenses? J Clin Invest 2005, 115:1702-1704
17. Tilton RG, Kawamura T, Chang KC, Ido Y, Bjercke RJ, Stephan CC, Brock TA, Williamson JR: Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor. J Clin Invest 1997, 99:2192-2202
18. Shen XD, Ke B, Zhai Y, Gao F, Anselmo D, Lassman CR, Busuttil RW, Kupiec-Weglinski JW: Stat4 and Stat6 signaling in hepatic ischemia/reperfusion injury in mice: HO-1 dependence of Stat4 disruption-mediated cytoprotection. Hepatology 2003, 37:296-303
19. Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, Cejalvo D: Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury: modulating effects of FK506 and cyclosporine. Transplantation 1993, 55:1265-1272
20. Ke B, Shen XD, Gao F, Busuttil RW, Lowenstein PR, Castro MG, Kupiec-Weglinski JW: Gene therapy for liver transplantation using adenoviral vectors: CD40-CD154 blockade by gene transfer of CD40Ig protects rat livers from cold ischemia and reperfusion injury. Mol Ther 2003, 9:38-45
21. Rudiger HA, Graf R, Clavien PA: Liver ischemia: apoptosis as a central mechanism of injury. J Invest Surg 2003, 16:149-159
22. Bilbao G, Contreras JL, Eckhoff DE, Mikheeva G, Krasnykh V, Douglas JT, Thomas FT, Thomas JM, Curiel DT: Reduction of ischemia-reperfusion injury of the liver by in vivo adenovirus-mediated gene transfer of the antiapoptotic Bcl-2 gene. Ann Surg 1999, 230:185-193
23. Sawitzki B, Amersi F, Ritter T, Fisser M, Shen XD, Ke B, Busuttil RW, Volk HD, Kupiec-Weglinski JW: Upregulation of Bag-1 by ex vivo gene transfer protects rat livers from ischemia/reperfusion injury. Hum Gene Ther 2002, 13:1495-1504
24. Wang N, Minatoguchi S, Chen X, Uno Y, Arai M, Lu C, Takemura G, Fujiwara T, Fujiwara H: Antidiabetic drug miglitol inhibits myocardial apoptosis involving decreased hydroxyl radical production and Bax expression in an ischaemia/reperfusion rabbit heart. Br J Pharmacol 2004, 142:983-990
25. Katori M, Busuttil RW, Kupiec-Weglinski JW: Heme oxygenase-1 system in organ transplantation. Transplantation 2002, 74:905-912
26. Shen XD, Ke B, Zhai Y, Amersi F, Gao F, Anselmo DM, Busuttil RW, Kupiec-Weglinski JW: CD154-CD40 T-cell costimulation pathway is required in the mechanism of hepatic ischemia/reperfusion injury, and its blockade facilitates and depends on heme oxygenase-1 mediated cytoprotection. Transplantation 2002, 74:315-319
27. Ferrara N, Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 1997, 18:4-25
28. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995, 1:27-31
29. Isner J, Pieczek A, Schainfeld R, Blair R, Haley L, Asahara T, Rosenfield K, Razvi S, Walsh K, Symes J: Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 1996, 348:370-374
30. Celletti F, Waugh J, Amabile P, Brendolan A, Hilfiker P, Dake M: Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med 2001, 7:425-429
31. Detmar M, Brown LF S, MP, Elicker BM, Velasco P, Richard L, Fukumura D, Monsky W, Claffey KP, Jain RK: Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol 1998, 111:1-6
32. Epstein S, Kornowski R, Fuchs S, Dvorak H: Angiogenesis therapy: amidst the hype, the neglected potential for serious side effects. Circulation 2001, 104:115-119
33. Thurston G, Suri C, Smith K, McClain J, Sato T, Yancopoulos G, McDonald D: Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999, 286:2511-2514
34. Uchida J, Kanai K, Asano K, Watanabe S, Hisamitsu T, Suzaki H: Influence of fluticasone propionate on the production of vascular endothelial growth factor and basic fibroblast growth factor from nasal fibroblasts in vitro. In Vivo 2004, 18:767-770
35. Melter M, Reinders ME, Sho M, Pal S, Geehan C, Denton MD, Mukhopadhyay D, Briscoe DM: Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo. Blood 2000, 96:3801-3808
36. Reinders ME, Sho M, Robertson SW, Geehan CS, Briscoe DM: Proangiogenic function of CD40 ligand-CD40 interactions. J Immunol 2003, 171:1534-1541
37. Luo Z, Diaco M, Murohara T, Ferrara N, Isner J, Symes J: Vascular endothelial growth factor attenuates myocardial ischemia-reperfusion injury. Ann Thorac Surg 1997, 64:993-998
38. van der Zee R, Murohara T, Luo Z, Zollmann F, Passeri J, Lekutat C, Isner JM: Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 1997, 95:1030-1037
39. Redaelli CA, Semela D, Carrick FE, Ledermann M, Candinas D, Sauter B, Dufour JF: Effect of vascular endothelial growth factor on functional recovery after hepatectomy in lean and obese mice. J Hepatol 2004, 40:305-312
40. Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, Thistlethwaite PA: Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 2000, 342:626-633
41. Jung JE, Lee HG, Cho IH, Chung DH, Yoon SH, Yang YM, Lee JW, Choi S, Park JW, Ye SK, Chung MH: STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells. FASEB J 2005, 19:1296-1298